Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7 USD | 0.00% | -4.76% | -41.67% |
Business Summary
Number of employees: 18
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sumit Aggarwal
CEO | Chief Executive Officer | - | 21-03-31 |
Daniel Geffken
DFI | Director of Finance/CFO | 67 | 20-10-31 |
Ali Hariri
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-07 |
Barbara Ryan
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Rubin
BRD | Director/Board Member | 63 | 14-04-30 |
Alan Walts
BRD | Director/Board Member | 64 | 21-03-31 |
Sumit Aggarwal
CEO | Chief Executive Officer | - | 21-03-31 |
Lindsay Androski
BRD | Director/Board Member | - | 22-07-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,143,390 | 3,006,085 ( 95.63 %) | 0 | 95.63 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.67% | 2.31M | |
+17.41% | 124B | |
+15.62% | 109B | |
-6.80% | 23.84B | |
+1.98% | 22.42B | |
-14.29% | 17.5B | |
-9.40% | 16.61B | |
-37.63% | 16.43B | |
+2.28% | 13.4B | |
+26.02% | 11.47B |
- Stock Market
- Equities
- ELOX Stock
- Company Eloxx Pharmaceuticals, Inc.